Giant Renal Angiomyolipomas and Pulmonary Lymphangioleiomyomatosis: Follow-up Report after More than a Decade

Saudi J Kidney Dis Transpl. 2023 Nov 1;34(6):671-675. doi: 10.4103/sjkdt.sjkdt_324_21. Epub 2024 May 9.

Abstract

Renal angiomyolipomas (AMLs) and pulmonary lymphangioleiomyomatosis (LAM) are two major presentations of tuberous sclerosis (TS), an autosomal dominant multisystem disorder. Renal AMLs can lead to life-threatening complications like hemorrhage and cause progressive renal failure requiring dialysis and kidney transplant. mTOR inhibitors showed promising results in TS patients with renal AMLs, LAM, and subependymal giant cell astrocytomas. This case report is a follow-up of a patient we reported in 2010 with giant AMLs and LAM who required an emergency nephrectomy for massive hemorrhage from giant left-sided AMLs.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Angiomyolipoma* / complications
  • Angiomyolipoma* / diagnostic imaging
  • Angiomyolipoma* / surgery
  • Female
  • Hemorrhage / etiology
  • Humans
  • Kidney Neoplasms* / complications
  • Kidney Neoplasms* / pathology
  • Kidney Neoplasms* / surgery
  • Lung Neoplasms* / complications
  • Lung Neoplasms* / surgery
  • Lymphangioleiomyomatosis* / complications
  • Lymphangioleiomyomatosis* / surgery
  • Nephrectomy*
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Tuberous Sclerosis / complications
  • Tuberous Sclerosis / surgery
  • Tumor Burden